Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New app aims to take the guesswork out of insulin dosing

NCT ID NCT06529705

Summary

This study tested a smartphone app called EkiYou V2, designed to help adults with diabetes who take multiple daily insulin injections. For six weeks, the app provided advice on how much insulin to take with meals and for background needs, automatically adjusting its suggestions over time. The main goal was to see if using the app was safe and could help people spend more time in their target blood sugar range.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, France, 34000, France

Conditions

Explore the condition pages connected to this study.